?DATA MANAGEMENT AND REPORTING GROUP High-quality clinical data management has been a cornerstone of Rho services since its inception. Over the last 2 decades, Rho has served as the coordinating center for numerous NIH-sponsored observational studies and clinical trials, which has given us extensive experience developing, implementing, and maintaining innovative and reliable data systems for clinical research. In anticipation of the consolidation of study coordination activities across DAIT consortia, Rho has worked over the last year to standardize methods and processes across our current consortia. The Data Management and Reporting Group Component will provide?across the 3 disease groups? high-quality, integrated, and secure information management systems and well-developed procedures for the collection of clinical and mechanistic data, the randomization of study subjects, the tracking of specimen collection and distribution, and the reporting of safety data. New DAIT studies coordinated by the Center will use the following systems for data management and reporting: ? Medidata Rave (an industry-leading, state-of-the-art, web-based data management tool) for the receipt, entry, verification, processing, correcting, storage, tracking, transmission and reporting on all clinical data and clinical laboratory data. Medidata Rave minimizes routine data entry errors and boosts efficiency through robust data validation functionality that effectively turns data capture and data cleaning into 1 process. ? RhoRAND? for 24-7 access to participant registration and randomization using web-based or interactive voice response technology. Non-computerized methods will be available if needed. ? Oracle Argus safety data system for entering, tracking, coding, reporting, analyzing, and archiving SAE data for clinical studies in accordance with federal and international regulations. Rho will carefully and comprehensively monitor accruing study data for enrollment status, visit and procedure completion status, and safety triggers. RhoPortal will be used across the DAIT Consortia to provide near real-time access to information about study progress. Any data quality or study progress metric that the Consortia Investigators or DAIT personnel wish to see routinely can be made available via RhoPortal. We will use the CDISC CDASH standard for clinical data management for new studies managed by the Center. CDASH provides a study with a library of data elements that are also an industry standard and is an excellent starting point for efficiently setting up a clinical data management system. Rho has already begun the process of developing standards for forms and variables that do not exist in CDASH, but which are common across our studies and therapeutic areas. This ?RhoDASH? global library will grow organically over time, and will allow us to store final study data in a standard format that can be uploaded to data sharing portals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Program Project or Center with Complex Structure Cooperative Agreement (UM2)
Project #
1UM2AI117870-01
Application #
8892717
Study Section
Special Emphasis Panel (ZAI1-PA-I (J2))
Project Start
2015-05-07
Project End
2022-04-30
Budget Start
2015-05-07
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
$2,205,527
Indirect Cost
$818,403
Name
Rho Federal Systems Division, Inc.
Department
Type
DUNS #
362726007
City
Chapel Hill
State
NC
Country
United States
Zip Code
27517
Calabrese, Sarah K; Earnshaw, Valerie A; Krakower, Douglas S et al. (2018) A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav 22:1122-1138
Gill, Michelle A; Liu, Andrew H; Calatroni, Agustin et al. (2018) Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol 141:1735-1743.e9
Wildfire, Jeremy; Bailey, Ryan; Krouse, Rebecca Z et al. (2018) The Safety Explorer Suite: Interactive Safety Monitoring for Clinical Trials. Ther Innov Regul Sci 52:696-700
Simpson, Eric L; Villarreal, Miguel; Jepson, Brett et al. (2018) Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype. J Invest Dermatol 138:2224-2233
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
Gergen, Peter J; Mitchell, Herman E; Calatroni, Agustin et al. (2018) Sensitization and Exposure to Pets: The Effect on Asthma Morbidity in the US Population. J Allergy Clin Immunol Pract 6:101-107.e2
du Toit, George; Sayre, Peter H; Roberts, Graham et al. (2018) Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort. J Allergy Clin Immunol 141:1343-1353
Calabrese, Sarah K; Krakower, Douglas S; Mayer, Kenneth H (2017) Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities. Am J Public Health 107:1883-1889
Scadding, Guy W; Calderon, Moises A; Shamji, Mohamed H et al. (2017) Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial. JAMA 317:615-625
Hoch, Heather E; Calatroni, Agustin; West, Joseph B et al. (2017) Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index. J Allergy Clin Immunol 140:1130-1137.e5

Showing the most recent 10 out of 33 publications